Ocular Manifestations of Leprosy 

  • Author: Eva C Kim, MD; Chief Editor: Hampton Roy Sr, MD   more...
 
Updated: Jun 15, 2011
 

Overview

In patients with leprosy (Hansen disease), the eyes frequently are affected with lagophthalmos, loss of eyebrows, corneal exposure, keratitis, uveitis, scleritis, leproma of the conjunctiva and sclera, retinal pearls, and loss of sensation with corneal ulceration with scarring.[1, 2, 3] At the United States Public Health Service (USPHS) Hospital in San Francisco, the incidence of leprotic uveal infections in patients with Hansen disease is 6-7%.

Ocular therapy depends on the manifestations and may involve medical or surgical measures.

Go to Leprosy and Pediatric Leprosy for complete

Next

Clinical Presentation

Ocular manifestations of Hansen disease include the following:

  • Insidious chronic anterior uveitis (chronic plasmoid iridocyclitis; see the image below)
  • Posterior synechia, keratic precipitates, iris pearls, complicated cataract, vitreous opacities, retinal detachment, secondary glaucoma, and phthisis bulbi
  • Diffuse plastic reactions (acute diffuse plasmoid iridocyclitis)
  • Isolated leproma
  • Posterior uveal involvement (rare) - Retinal pearls, uveal effusionHansen disease plasmoid (plastic) iridocyclitis. Hansen disease plasmoid (plastic) iridocyclitis.

Beading of corneal nerves (abnormally wide edematous nerves) is probably the earliest detectable ocular finding (see the image below). These abnormal nerves are sometimes difficult to detect and are seen best by means of slit-lamp broad beam, retroillumination, or sclerotic scatter. The opacification and beading are due to the localization and multiplication of bacilli in or adjacent to nerves, with or without infiltration of plasma cells, lymphocytes, and epithelioid cells.

Beaded corneal nerve of a patient with Hansen diseBeaded corneal nerve of a patient with Hansen disease.

The corneal stroma then reacts, and the cornea becomes covered with milky chalky deposits, causing a keratitis pathognomonic of Hansen disease. These avascular punctate subepithelial opacities usually require a slit-lamp examination for their detection. The lesions are seen between the epithelium and the Bowman membrane, and they later spread and become confluent. They are lepromas containing acid-fast organisms, lymphocytes, and macrophages, and some become calcified and can destroy the Bowman membrane.

With progression of the disease, superficial and deep vascularization develops with reduced vision. In Carville Public Health Service (PHS) Hospital, 16% of the first ocular lesions noticed were episcleritis, scleritis, or uveitis. This type of episcleritis usually has early pain, tenderness and circumcorneal injection, and lack of exudates or bacteria. Late lepromas may develop in the episcleral area because this is a low-temperature area. Bacilli are present in the ciliary body and pass through the sclera, episclera, conjunctiva, cornea, and also into the anterior chamber and iris.

Iris pearls with uveitis represent miliary lepromas and are diagnostic lesions (see the image below). They are creamy round spheres, usually less than 0.5 mm in diameter, that are typically located near the papillary border or the chamber angle; they may also migrate and fuse with other pearls. Iris pearls contain acid-fast material, remains of lepromatous cellular debris, and calcium salts. They form deep in the iris stroma and are extruded to the surface, where they may persist for months or years.

Hansen disease. Iris pearl avascular keratitis. Hansen disease. Iris pearl avascular keratitis.

Leprous pannus usually develops in the superior limbus and later extends around the entire corneal circumference.

The uveitis in Hansen disease may follow a severe and prolonged course and may be associated with extensive anterior or posterior synechia. After repeated attacks, extensive iris atrophy and intractable glaucoma develop.

Uveal effusion in association with conjunctival and episcleral hyperemia (see the first image below), as well as retinal pearls (see the second image below), may occur in rare cases.

Retinal scar uveal effusion of a patient with HansRetinal scar uveal effusion of a patient with Hansen disease. Retinal pearl of a patient with Hansen disease. Retinal pearl of a patient with Hansen disease.
Previous
Next

Diagnosis

Typical systemic disease is confirmed by histopathology of corneal conjunctival or subcutaneous skin scrapings (see the first image below), anterior chamber[4] or vitreous taps (see the second image below), or skin tissue biopsy (see the third image below). Findings show multiple acid-fast bacilli with acid-fast stains or Fite-Faraco stain, along with iris pearls.

Hansen disease corneal scraping acid-fast bacilli.Hansen disease corneal scraping acid-fast bacilli. Hansen disease anterior chamber tap acid-fast baciHansen disease anterior chamber tap acid-fast bacilli globi. Hansen disease skin biopsy Fite stain. Hansen disease skin biopsy Fite stain.

Lagophthalmos (see the image below) or unexplained seventh nerve weakness, associated with skin or neurologic disorders, should be considered in the differential diagnosis of Hansen disease. Exposure keratitis and corneal ulceration also may occur, especially in association with decreased corneal sensation, thickened eyelids and incomplete blinking, decreased mucin and meibomian secretions, and denervation of the lacrimal gland.

Lagophthalmos of a patient with Hansen disease. Lagophthalmos of a patient with Hansen disease.
Previous
Next

Treatment & Management

Medical therapy

Ocular therapy depends on the manifestations. Aggressive treatment of iridocyclitis is probably one of the more important considerations, as well as protection of anesthetic corneas from exposure, erosion, and ulceration in the face of lagophthalmos.

If corneal staining is demonstrated by fluorescein solution, frequent use of artificial tears (1% methylcellulose drops) or lubricating ointment is indicated. Commercially available moisture shields, plastic wrap (eg, Saran Wrap), or swimming goggles may be used to occlude the eyes. Taping the eyelids closed at night is also useful. Secondary glaucoma may be treated with acetazolamide (Diamox) to reduce intraocular fluid production and reduce intraocular tension.

Plasmoid (plastic) iridocyclitis with anterior uveitis should be treated aggressively to avoid synechia, iris bombé, and other complications.

Surgical therapy

Cataracts may be treated with reduction of vision or surgical extraction. (The authors generally elect to be conservative and not to insert intraocular lenses, because of the problems of repeat uveitis and synechia.)

Iris bombé due to posterior synechia and glaucoma may be treated with sector iridectomies to help reduce intraocular pressure and improve vision in some patients with complicated cataracts or corneal opacities.

Eyebrow loss may be treated with makeup, tattooing, or free grafts from the scalp. Lagophthalmos due to seventh nerve palsy may be treated by a partial tarsorrhaphy or lateral canthoplasty or other lid-shortening procedures. Temporalis transfers are also useful in some patients.[5, 6]

Entropion or ectropion should be treated by appropriate surgical procedures. Trichiasis may be treated with repeated epilation or with electrolysis. In patients who have a painful blind eye as a result of glaucoma, enucleation may be the treatment of choice.

Consultations

With the present treatment available, the sequelae can be minimized, but the deformities can be stigmatizing for the patient and their families. If the disease goes untreated, the disability aspect is tremendous.

It is strongly recommended that a trained leprologist, if available, be included in the treatment of Hansen disease patients with ocular manifestations.

Previous
 
Contributor Information and Disclosures
Author

Eva C Kim, MD  Fellow in Ocular Inflammation/Uveitis, Francis I Proctor Foundation for Research in Ophthalmology, Department of Ophthalmology, University of California at San Francisco

Disclosure: Nothing to disclose.

Specialty Editor Board

Jack L Wilson, PhD  Distinguished Professor, Department of Anatomy and Neurobiology, University of Tennessee Health Science Center College of Medicine

Jack L Wilson, PhD is a member of the following medical societies: American Association of Anatomists, American Association of Clinical Anatomists, and American Heart Association

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Mark T Duffy, MD, PhD  Consulting Staff, Division of Oculoplastic, Orbito-facial, Lacrimal and Reconstructive Surgery, Green Bay Eye Clinic, BayCare Clinic; Medical Director, Advanced Cosmetic Solutions, A BayCare Clinic

Mark T Duffy, MD, PhD is a member of the following medical societies: American Academy of Ophthalmology, American Medical Association, American Society of Ophthalmic Plastic and Reconstructive Surgery, Sigma Xi, and Society for Neuroscience

Disclosure: Allergan - Botox Cosmetic Consulting fee Consulting

Chief Editor

Hampton Roy Sr, MD  Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences

Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology

Disclosure: Nothing to disclose.

Acknowledgments

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous coauthors Joseph B Michelson, MD, FACS, and James M Arrington, MD, to the development and writing of this article.

References
  1. Centers for Disease Control and Prevention. Hansen's disease Updated November 19, 2009. Available at http://www.cdc.gov/nczved/divisions/dfbmd/diseases/hansens_disease/technical.html. Accessed May 26, 2011.

  2. World Health Organization (WHO). WHO Expert Committee on Leprosy. 7th Report. Available at http://www.who.int/lep/resources/Expert.pdf. Accessed May 26, 2011.

  3. WHO. Leprosy: global situation. World Health Organization. Available at http://www.who.int/lep/situation/en/. Accessed January 27, 2010.

  4. Michelson JB, Roth AM, Waring GO 3rd. Lepromatous iridocyclitis diagnosed by anterior chamber paracentesis. Am J Ophthalmol. Oct 1979;88(4):674-9. [Medline].

  5. Johnson HA. . A modification of the gilles, temporalis transfer for the surgical treatment of the lagophthalmos of leprosy. Plast Reconst Surg. 1962;30:378.

  6. Masters FW, Robinson DW, Simons JN. Temporalis transfer for lagopthalmos due to seventh nerve palsy. Am J Surg. Oct 1965;110(4):607-11. [Medline].

Previous
Next
 
Classification of Hansen disease after Paul Fasal, MD.
Hansen disease skin biopsy Fite stain.
Hansen disease plasmoid (plastic) iridocyclitis.
Hansen disease skin biopsy foam cells.
Hansen disease skin biopsy tuberculoid.
Hansen disease corneal scraping acid-fast bacilli.
Hansen disease anterior chamber tap acid-fast bacilli globi.
Hansen disease. Tuberculoid hand.
Hansen disease. Lucio phenomenon.
Ear nodules of a patient with Hansen disease.
Facial nodules of a patient with Hansen disease.
Lagophthalmos of a patient with Hansen disease.
Tuberculoid leg ulcer and biopsy site arm of a patient with Hansen disease.
Claw hands of a patient with Hansen disease.
Claw hands of a patient with Hansen disease.
Claw hands of a patient with Hansen disease.
Lagophthalmos seventh nerve of a patient with Hansen disease.
Hansen disease. Corneal scar seventh nerve exposure.
Hansen disease. Facial nodule and erythema nodosum leprosum.
Corneal neovascularization iris pearls of a patient with Hansen disease.
Avascular keratitis of a patient with Hansen disease.
Corneal neovascularization of a patient with Hansen disease.
Hansen disease. Corneal sensitivity determination with nylon monofilament.
Beaded corneal nerve of a patient with Hansen disease.
Hansen disease. Iris pearl avascular keratitis.
Temporal thin eyebrows of a patient with Hansen disease.
Cosmetic cover thin eyebrows of a patient with Hansen disease.
Thin eyebrows of a patient with Hansen disease.
Cataracts glaucoma synechia of a patient with Hansen disease.
Retinal scar uveal effusion of a patient with Hansen disease.
Retinal pearl of a patient with Hansen disease.
Nodular episcleritis of a patient with Hansen disease.
Episcleritis of a patient with Hansen disease.
Plasmoid (plastic) iridocyclitis of a patient with Hansen disease.
Purple skin from clofazimine of a patient with Hansen disease.
A 6-year-old boy with Hansen disease.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.